A multimeric carcinoembryonic antigen signal inhibits the activation of human T cells by a SHP‐independent mechanism: A potential mechanism for tumor‐mediated suppression of T‐cell immunity
暂无分享,去创建一个
Tai-Gyu Kim | C. Kang | Kyoo-a Lee | Yoon-Sook Lee | Eun-Ah Bae | Eun-kyung Kim | Y. Song | Yoon‐Sook Lee
[1] J. Gariépy,et al. The carcinoembryonic antigen IgV‐like N domain plays a critical role in the implantation of metastatic tumor cells , 2014, Molecular oncology.
[2] Yun Li,et al. CEACAM1 regulates Fas-mediated apoptosis in Jurkat T-cells via its interaction with β-catenin. , 2013, Experimental cell research.
[3] P. Rao,et al. The influence of metastatic site on the expression of CEA and cellular localization of β‐catenin in colorectal cancer , 2013, Journal of gastroenterology and hepatology.
[4] W. Zimmermann,et al. Role of CEACAM1 and CEACAM20 in an In Vitro Model of Prostate Morphogenesis , 2013, PloS one.
[5] F. Schildberg,et al. Liver sinusoidal endothelial cells contribute to CD8 T cell tolerance toward circulating carcinoembryonic antigen in mice , 2012, Hepatology.
[6] R. A. Forse,et al. Carcinoembryonic antigen (CEA) and its receptor hnRNP M are mediators of metastasis and the inflammatory response in the liver , 2011, Clinical & Experimental Metastasis.
[7] F. Gounari,et al. β-Catenin Inhibits T Cell Activation by Selective Interference with Linker for Activation of T Cells–Phospholipase C-γ1 Phosphorylation , 2011, The Journal of Immunology.
[8] M. Ostrowski,et al. CEACAM1 Dynamics during Neisseria gonorrhoeae Suppression of CD4+ T Lymphocyte Activation1 , 2008, The Journal of Immunology.
[9] Natsuko Nakamura,et al. Glycosylation-Dependent Interactions of C-Type Lectin DC-SIGN with Colorectal Tumor-Associated Lewis Glycans Impair the Function and Differentiation of Monocyte-Derived Dendritic Cells1 , 2008, The Journal of Immunology.
[10] A. Watson,et al. Different Forms of Helper Tolerance to Carcinoembryonic Antigen: Ignorance and Regulation , 2007, Clinical Cancer Research.
[11] J. Jessup,et al. Carcinoembryonic antigen inhibits anoikis in colorectal carcinoma cells by interfering with TRAIL-R2 (DR5) signaling. , 2007, Cancer research.
[12] Christof R Hauck,et al. CEACAMs: their role in physiology and pathophysiology , 2006, Current Opinion in Cell Biology.
[13] Nagendra Singh,et al. Lck couples Shc to TCR signaling. , 2006, Cellular signalling.
[14] S. Gray-Owen,et al. CEACAM1: contact-dependent control of immunity , 2006, Nature Reviews Immunology.
[15] C. Münz,et al. Virus-specific CD4+ T cells: ready for direct attack , 2006, The Journal of experimental medicine.
[16] F. Naghibalhossaini,et al. Evidence for CEA release from human colon cancer cells by an endogenous GPI-PLD enzyme. , 2006, Cancer letters.
[17] O. Lantz,et al. CD4 cells can be more efficient at tumor rejection than CD8 cells. , 2005, Blood.
[18] G. Meijer,et al. Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin. , 2005, Cancer research.
[19] M. Bevan. Helping the CD8+ T-cell response , 2004, Nature Reviews Immunology.
[20] J. Hanna,et al. Biological function of the soluble CEACAM1 protein and implications in TAP2‐deficient patients , 2004, European journal of immunology.
[21] J. Shively,et al. The Cell-Cell Adhesion Molecule Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 1 Inhibits IL-2 Production and Proliferation in Human T Cells by Association with Src Homology Protein-1 and Down-Regulates IL-2 Receptor1 , 2004, The Journal of Immunology.
[22] Hao Shen,et al. Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory , 2003, Science.
[23] M. Duffy,et al. Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. , 2003, European journal of cancer.
[24] S. Gray-Owen,et al. Neisserial binding to CEACAM1 arrests the activation and proliferation of CD4+ T lymphocytes , 2002, Nature Immunology.
[25] M. N. Poy,et al. Shc and CEACAM1 Interact to Regulate the Mitogenic Action of Insulin* , 2002, The Journal of Biological Chemistry.
[26] A. Rao,et al. Partners in transcription: NFAT and AP-1 , 2001, Oncogene.
[27] N. Restifo,et al. Cutting Edge: CD4+ T Cell Control of CD8+ T Cell Reactivity to a Model Tumor Antigen , 2000, The Journal of Immunology.
[28] W. Zimmermann,et al. Redefined nomenclature for members of the carcinoembryonic antigen family. , 1999, Experimental cell research.
[29] S. Hammarström. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. , 1999, Seminars in cancer biology.
[30] Hii,et al. Direct evidence that ERK regulates the production/secretion of interleukin‐2 in PHA/PMA‐stimulated T lymphocytes , 1999, Immunology.
[31] S. Greco,et al. Monitoring carcinoembryonic antigen in colorectal cancer: Is it still useful? , 1998, Surgery Today.
[32] T. Kelly,et al. Carcinoembryonic antigen induces cytokine expression in Kuppfer cells: implications for hepatic metastasis from colorectal cancer. , 1996, Cancer research.
[33] P. Thomas,et al. Processing of carcinoembryonic antigen by Kupffer cells: recognition of a penta-peptide sequence. , 1996, Archives of biochemistry and biophysics.
[34] T R Fleming,et al. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. , 1993, JAMA.
[35] P. Sammartino,et al. Role of CEA, TPA, and Ca 19-9 in the early detection of localized and diffuse recurrent rectal cancer , 1992, Diseases of the colon and rectum.
[36] Abraham Fuks,et al. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule , 1989, Cell.
[37] Phil Gold,et al. SPECIFIC CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEM , 1965, The Journal of experimental medicine.
[38] Lanfen Chen,et al. Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 Inhibits Proximal TCR Signaling by Targeting ZAP-70 , 2008 .
[39] C. Stanners,et al. Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. , 2002, Neoplasia.
[40] J. Thompson,et al. Molecular cloning and expression of carcinoembryonic antigen gene family members. , 1995, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[41] J. Beatty,et al. CEA-related antigens: molecular biology and clinical significance. , 1985, Critical reviews in oncology/hematology.